AHS 2022 | Recent updates from the previous NIH roadmap for migraines

Michael Oshinsky, PhD, National Institutes of Health (NIH), Bethesda, MD, discusses recent updates from the previous year’s NIH roadmap for migraines. In the last few years, there has been a great increase in interest from the research community concerning the NIH. Since 2016, there has been a doubling of funds being distributed to the research community – presenting exciting new opportunities for current and future projects concerning migraine research and its impact on patients. This interview took place at the 2022 American Headache Society (AHS) Annual Scientific Meeting in Denver, CO.